Boliang Cao (Brian)

Title: Boliang Cao (Brian): Innovator in Monoclonal Antibody Research

Introduction

Boliang Cao, also known as Brian, is an accomplished inventor based in Ada, MI (US). He has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. His work focuses on the receptor tyrosine kinase Met, which is associated with aggressive metastatic phenotypes in various human solid tumors.

Latest Patents

Boliang Cao holds a patent for a monoclonal antibody that binds cMet (HGFR) in formalin-fixed and paraffin-embedded tissues. This patent describes a monoclonal antibody named Met4, which is specific for Met. The Met4 antibody is particularly useful for detecting Met in formalin-fixed tissue. The patent also outlines methods for using the Met4 antibody for detection, diagnosis, prognosis, and evaluating therapeutic efficacy. He has 1 patent to his name.

Career Highlights

Throughout his career, Boliang Cao has worked at notable institutions such as the Van Andel Research Institute and the Fred Hutchinson Cancer Center. His research has contributed to advancements in cancer diagnostics and therapeutics, particularly in understanding the role of Met in tumor biology.

Collaborations

Boliang has collaborated with esteemed colleagues in the field, including George F. Vande Woude and Beatrice S. Knudsen. These collaborations have furthered the impact of his research and innovations in cancer treatment.

Conclusion

Boliang Cao is a prominent figure in the field of monoclonal antibody research, with a focus on the Met receptor. His innovative work has the potential to improve cancer detection and treatment, making significant strides in the biomedical field.